Board to Consider Revised Audited Annual Accounts for the Year ended March 31, 2015 & Dividend on August 11, 2015

• Security Code: 524715
• Company: SUNPHARMA

With reference to the earlier letter dated July 28, 2015 regarding Q1 results on August 11, 2015, Sun Pharmaceutical Industries Ltd has now informed BSE that the Board of Directors of the Company at its meeting scheduled to be held on August 11, 201 5 would also transact the following business:

1. Consideration of the revised audited annual accounts of the Company for the year ended March 31, 2015 after giving the effect to the Scheme of Amalgamation of SPGI into SPIL and the proposal for payment of dividend.

2. Consideration of the recommendation of payment of dividend on equity shares for the year ended March 31, 2015 subject to the approval of the shareholders at the ensuing Annual General Meeting.